🇺🇸 hypoglycemic Agents(metformin) in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 22 April 2025 – 22 April 2026
Total reports: 4

Most-reported reactions

Blood Potassium Increased — 1 report (25%)
Dyspnoea — 1 report (25%)
Oedema — 1 report (25%)
Renal Failure — 1 report (25%)

Source database →

Other Endocrinology / Diabetes approved in United States

Frequently asked questions

Is hypoglycemic Agents(metformin) approved in United States?

hypoglycemic Agents(metformin) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for hypoglycemic Agents(metformin) in United States?

First Affiliated Hospital of Wenzhou Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.